Profile
Paul F.
Howley worked as a Research Director at Bavarian Nordic A from 1998 to 2002.
He then worked as a Technical Director at Prescient Therapeutics Ltd.
from 2002 to 2008.
After that, he worked as a Director of Virology & Protein Chemistry at Sentinext Therapeutics Sdn.
Bhd.
Dr. Howley received his undergraduate degree from The University of Reading in 1985.
Former positions of Paul F. Howley
| Companies | Position | End |
|---|---|---|
| PRESCIENT THERAPEUTICS LIMITED | Chief Tech/Sci/R&D Officer | 2007-12-31 |
| BAVARIAN NORDIC A/S | Chief Tech/Sci/R&D Officer | 2001-12-31 |
Sentinext Therapeutics Sdn. Bhd.
 Sentinext Therapeutics Sdn. Bhd. BiotechnologyHealth Technology Sentinext Therapeutics Sdn. Bhd. develops vaccines and therapeutics for tropical infectious diseases. Its pharmaceutical research and development focuses on EV71, polio, influenza and dengue diseases. The company was founded by Mary Jane Cardosa and Peter Samuel Wulff in 2009 and is headquartered in Penang, Malaysia. | Corporate Officer/Principal | - |
Training of Paul F. Howley
| The University of Reading | Undergraduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 2 |
|---|---|
| BAVARIAN NORDIC A/S | Health Technology |
| PRESCIENT THERAPEUTICS LIMITED | Health Technology |
| Private companies | 1 |
|---|---|
Sentinext Therapeutics Sdn. Bhd.
Sentinext Therapeutics Sdn. Bhd. BiotechnologyHealth Technology Sentinext Therapeutics Sdn. Bhd. develops vaccines and therapeutics for tropical infectious diseases. Its pharmaceutical research and development focuses on EV71, polio, influenza and dengue diseases. The company was founded by Mary Jane Cardosa and Peter Samuel Wulff in 2009 and is headquartered in Penang, Malaysia. | Health Technology |
- Stock Market
- Insiders
- Paul F. Howley
